{"DataElement":{"publicId":"7090287","version":"1","preferredName":"Malignant Neoplasm Overall Stage Grouping Stage","preferredDefinition":"The overall stage grouping, an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, of a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"7090254v1.0:7090268v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"7090254","version":"1","preferredName":"Malignant Neoplasm Overall Stage Grouping","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Including everything._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"2186369v1.0:7090252v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7090252","version":"1","preferredName":"Overall Stage Grouping","preferredDefinition":"Including everything.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"C25605:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"99738B21-948E-778C-E053-F662850AB17D","latestVersionIndicator":"Yes","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"99738B21-949F-778C-E053-F662850AB17D","latestVersionIndicator":"Yes","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"MORENOC","dateModified":"2020-03-09","changeDescription":"3/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7090268","version":"1","preferredName":"Malignant Neoplasm Overall Stage","preferredDefinition":"The malignant neoplasm overall extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7090268v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV","ValueMeaning":{"publicId":"3203164","version":"1","preferredName":"Stage IV","longName":"3203164","preferredDefinition":"Cancer that has spread to distant anatomic sites beyond its original site of growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV","conceptCode":"C27971","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B9DB-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"997505B0-E305-6A24-E053-F662850A7802","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III","ValueMeaning":{"publicId":"3203160","version":"1","preferredName":"Stage III","longName":"3203160","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III","conceptCode":"C27970","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B94F-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"997505B0-E30F-6A24-E053-F662850A7802","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II","ValueMeaning":{"publicId":"3203157","version":"1","preferredName":"Stage II","longName":"3203157","preferredDefinition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II","conceptCode":"C28054","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B8DB-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"997505B0-E323-6A24-E053-F662850A7802","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I","ValueMeaning":{"publicId":"3179338","version":"1","preferredName":"Stage I","longName":"3179338","preferredDefinition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I","conceptCode":"C27966","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F8FD-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"997505B0-E32D-6A24-E053-F662850A7802","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0","ValueMeaning":{"publicId":"3203154","version":"1","preferredName":"Stage 0","longName":"3203154","preferredDefinition":"Cancer confined to the epithelium without invasion of the basement membrane.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0","conceptCode":"C28051","definition":"Cancer confined to the epithelium without invasion of the basement membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B867-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"997505B0-E341-6A24-E053-F662850A7802","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"997505B0-E34B-6A24-E053-F662850A7802","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"997505B0-E2D8-6A24-E053-F662850A7802","latestVersionIndicator":"Yes","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"MORENOC","dateModified":"2020-03-09","changeDescription":"3/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Overall stage","type":"Preferred Question Text","description":"Overall stage","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"99752C03-885D-65C4-E053-F662850AB013","latestVersionIndicator":"Yes","beginDate":"2019-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-12-11","modifiedBy":"MORENOC","dateModified":"2020-03-09","changeDescription":"3/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}